Latest News

Current and archived news underscoring key milestones that strengthen the market position and long‑term growth outlook for CyndRx.

News

 Take a look at our process of where we are today.

CyndRx has begun enrollment in the SEAL TO HEAL U.S. IDE clinical trial to assess the safety and effectiveness of the AbsorbaSeal™ 5.6.7F Vascular Closure Device.

Read more

CyndRx, LLC Receives Full FDA Approval of Investigational Device Exemption (IDE) to Initiate a U.S. Pivotal Trial for the AbsorbaSeal™ 5.6.7F Vascular Closure Device

Read more

CyndRx, LLC Finalizes CE Mark Trial with Strong Clinical Outcomes using AbsorbaSeal™ Vascular Closure Device

CyndRx, LLC, a medical device company focused on improving…
Read more

CyndRx, LLC Announces Completion of Enrollment in the AbsorbaSeal™ Vascular Closure Device CE Mark Trial

Read more